Dr Flavio Salazar-Onfray

Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile

Dr. Flavio Salazar Onfray is a Professor at the Disciplinary Program of Immunology in the Institute of Biomedical Sciences, Faculty of Medicine, University of Chile. He is a biologist from the University of Uppsala and gained his PhD from Karolinska Institute, Sweden. Dr. Salazar's research interests are focused on several aspects of tumor immunology, from basic research to clinical trials.

Dr. Salazar has led a multidisciplinary group that performed Phase I and Phase I/II clinical trials in Chile of cancer immunotherapy. From 2005 to 2022, he was Deputy Director of the Institute Millennium of Immunology and Immunotherapy, and is a former President of the Chilean Society of Immunology and a past President of the Latin American Association of Immunology Societies (ALAI). He founded two spin-off companies, Oncobiomed in 2002, dedicated to cellular immunotherapy technology transfer, and Bionex in 2007, dedicated to advising basic scientists in designing R&D applications. Dr. Salazar was Vice President of Research and Development at the University of Chile between 2014 and 2022 and Minister of Science, Technology, Knowledge, and Innovation from March to September 2022.

Updated 25 August 2023